Prelude Therapeutics
PRLD
#9213
Rank
NZ$0.12 B
Marketcap
$2.20
Share price
-4.62%
Change (1 day)
-66.90%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.51

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.85. In 2022 the company made an earnings per share (EPS) of -$4.32 a decrease over its 2021 EPS that were of -$4.29.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.51-18.82%
2022-$4.320.83%
2021-$4.29-61.3%
2020-$11.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.86 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA